Expertise in
16
conditions

Emmanuella Guenova

Lausanne, VD, CH 
Expertise in
16
conditions
Lausanne, VD, CH 

Overview

Emmanuella Guenova practices practicing medicine in Lausanne, Switzerland.

Ms. Guenova is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Non-Hodgkin Lymphoma.

She is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lausanne, VD 3001, Switzerland
Other Locations
Zurich, ZH, Switzerland
Kantonsspital St Gallen, St Gallen
Switzerland
Cantonal Hospital St. Gallen
Sankt Gallen, SG, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment
Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment
Enrollment Status: Terminated
Publish Date: February 22, 2024
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Prospective, Multicenter, Single-Arm Cohort Study of Photopheresis in the Treatment of Erythrodermic MF and SS
A Prospective, Multicenter, Single-Arm Cohort Study of Photopheresis in the Treatment of Erythrodermic MF and SS
Enrollment Status: Withdrawn
Publish Date: September 08, 2021
Intervention Type: Device, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

224 Total Publications

Does time matter? Rethinking the Temporal Dimension of Psoriasis.
Does time matter? Rethinking the Temporal Dimension of Psoriasis.
Journal: The British journal of dermatology
Published: August 28, 2026

Frequently Asked Questions about Emmanuella Guenova

Is Emmanuella Guenova a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Emmanuella Guenova is classified as an Elite expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emmanuella Guenova participate in research or clinical trials?

Yes. Emmanuella Guenova has published 224 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Emmanuella Guenova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Guenova's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile